You have been asked to design a randomised controlled trial to compare a new SGLT-2 inhibitor called zetaglifozin against another SGLT-2 inhibitor already on the market, dapagliflozin. | Medibuddy
13th February 2024

You have been asked to design a randomised controlled trial to compare a new SGLT-2 inhibitor called zetaglifozin against another SGLT-2 inhibitor already on the market, dapagliflozin.

You have been asked to design a randomised controlled trial to compare a new SGLT-2 inhibitor called zetaglifozin against another SGLT-2 inhibitor already on the market, dapagliflozin. 

Which of the following is FALSE?

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.